BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, Messana JM, Levin N, Rajagopalan S, Port FK, Wolfe RA, Saran R. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658-666. [PMID: 15806468 DOI: 10.1053/j.ajkd.2004.12.021] [Cited by in Crossref: 227] [Cited by in F6Publishing: 203] [Article Influence: 13.4] [Reference Citation Analysis]
Number Citing Articles
1 Watnick S. Quality of life and depression in CKD: improving hope and health. Am J Kidney Dis 2009;54:399-402. [PMID: 19700059 DOI: 10.1053/j.ajkd.2009.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Al-ali FS, El-sayed Abdelfattah M, Fawzy AA, Hamdy AF, Abdulla AE. Erythropoietin-stimulating agents in the management of anemia of end-stage renal disease patients on regular hemodialysis: A prospective randomized comparative study from Qatar: Erythropoietin-stimulating agents’ comparison. Hemodial Int 2015;19:33-43. [DOI: 10.1111/hdi.12181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Plantinga LC, Fink NE, Jaar BG, Huang IC, Wu AW, Meyer KB, Powe NR. Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis. Qual Life Res 2007;16:755-65. [PMID: 17286191 DOI: 10.1007/s11136-007-9176-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
4 Kumnig M, Rumpold G, Höfer S, König P, Holzner B, Giesinger J, Gamper E, Zabernigg A, Hoflehner A. Patient-reported outcome reference values for patients after kidney transplantation. Wien Klin Wochenschr 2014;126:15-22. [DOI: 10.1007/s00508-013-0448-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
5 Bagasha P, Namukwaya E, Leng M, Kalyesubula R, Mutebi E, Naitala R, Katabira E, Petrova M. Comparison of the health-related quality of life of end stage kidney disease patients on hemodialysis and non-hemodialysis management in Uganda. BMC Palliat Care 2021;20:52. [PMID: 33794849 DOI: 10.1186/s12904-021-00743-0] [Reference Citation Analysis]
6 Boateng EA, East L. THE IMPACT OF DIALYSIS MODALITY ON QUALITY OF LIFE: A SYSTEMATIC REVIEW: THE IMPACT OF DIALYSIS MODALITY ON QUALITY OF LIFE: A SYSTEMATIC REVIEW. Journal of Renal Care 2011;37:190-200. [DOI: 10.1111/j.1755-6686.2011.00244.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
7 Glenngård AH, Persson U, Schön S. Cost-effectiveness analysis of treatment with epoietin-alpha for patients with anaemia due to renal failure: the case of Sweden. Scand J Urol Nephrol 2008;42:66-73. [PMID: 17907051 DOI: 10.1080/00365590701561994] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
8 Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ. Prevalence of major depressive episode in CKD. Am J Kidney Dis 2009;54:424-32. [PMID: 19493599 DOI: 10.1053/j.ajkd.2009.03.017] [Cited by in Crossref: 108] [Cited by in F6Publishing: 91] [Article Influence: 8.3] [Reference Citation Analysis]
9 Portolés JM, de Francisco AL, Górriz JL, Martínez-Castelao A, López-Gómez JM, Arias M, de la Cruz JJ, Cases A, Fernández E, Aljama P. Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study. Kidney Int Suppl 2008;:S82-7. [PMID: 19034334 DOI: 10.1038/ki.2008.524] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Molsted S, Prescott L, Heaf J, Eidemak I. Assessment and clinical aspects of health-related quality of life in dialysis patients and patients with chronic kidney disease. Nephron Clin Pract. 2007;106:c24-c33. [PMID: 17409766 DOI: 10.1159/000101481] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
11 Feasel-Aklilu S, Marcus A, Parrott JS, Peters E, Byham-Gray L. Is Nutrition Specific Quality of Life Associated With Nutritional Status? J Ren Nutr 2018;28:283-91. [PMID: 29631758 DOI: 10.1053/j.jrn.2017.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Silver MR, Agarwal A, Krause M, Lei L, Stehman-breen C. Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease. The American Journal of Geriatric Pharmacotherapy 2008;6:49-60. [DOI: 10.1016/j.amjopharm.2008.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Joshee P, Wood AG, Wood ER, Grunfeld EA. Meta-analysis of cognitive functioning in patients following kidney transplantation. Nephrol Dial Transplant 2018;33:1268-77. [PMID: 28992229 DOI: 10.1093/ndt/gfx240] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
14 Dinwiddie LC, Burrows-hudson S, Peacock EJ. Stage 4 Chronic Kidney Disease: Preserving kidney function and preparing patients for stage 5 kidney disease. AJN, American Journal of Nursing 2006;106:40-51. [DOI: 10.1097/00000446-200609000-00024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
15 Aoike DT, Baria F, Kamimura MA, Ammirati A, Cuppari L. Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clin Exp Nephrol 2018;22:87-98. [PMID: 28643119 DOI: 10.1007/s10157-017-1429-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
16 Friedman AJ, Chen Z, Ford P, Johnson CA, Lopez AM, Shander A, Waters JH, van Wyck D. Iron deficiency anemia in women across the life span. J Womens Health (Larchmt) 2012;21:1282-9. [PMID: 23210492 DOI: 10.1089/jwh.2012.3713] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
17 Hashemi Hefz Abad F, Shabany Hamedan M. Comparison of Attitudes Regarding Quality of Life between Insulin-Treated Subjects with Diabetes Mellitus and Healthy Populations. Diabetes Metab J 2011;35:397-403. [PMID: 21977460 DOI: 10.4093/dmj.2011.35.4.397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
18 Rebollo Rubio A, Morales Asencio JM, Eugenia Pons Raventos M. Depression, anxiety and health-related quality of life amongst patients who are starting dialysis treatment. J Ren Care 2017;43:73-82. [PMID: 28239953 DOI: 10.1111/jorc.12195] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
19 Chin HJ, Song YR, Lee JJ, Lee SB, Kim KW, Na KY, Kim S, Chae DW. Moderately decreased renal function negatively affects the health-related quality of life among the elderly Korean population: a population-based study. Nephrol Dial Transplant 2008;23:2810-7. [PMID: 18372390 DOI: 10.1093/ndt/gfn132] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
20 Kuo YT, Chiu KM, Tsang YM, Chiu CM, Chien MY. Influence of Chronic Kidney Disease on Physical Function and Quality of Life in Patients after Coronary Artery Bypass Grafting. Cardiorenal Med 2015;5:237-45. [PMID: 26648940 DOI: 10.1159/000433447] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
21 Han SS, Kim KW, Na KY, Chae DW, Kim YS, Kim S, Chin HJ. Quality of life and mortality from a nephrologist's view: a prospective observational study. BMC Nephrol 2009;10:39. [PMID: 19930696 DOI: 10.1186/1471-2369-10-39] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
22 Lee SJ, Son H, Shin SK. Influence of frailty on health-related quality of life in pre-dialysis patients with chronic kidney disease in Korea: a cross-sectional study. Health Qual Life Outcomes 2015;13:70. [PMID: 26021987 DOI: 10.1186/s12955-015-0270-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
23 Kannenkeril D, Frost S, Nolde JM, Kiuchi MG, Carnagarin R, Lugo-Gavidia LM, Chan J, Joyson A, Matthews VB, Herat LY, Azzam O, Mehdizadeh M, Vignarajan J, Kanagasingam Y, Schlaich MP. Microvascular changes at different stages of chronic kidney disease. J Clin Hypertens (Greenwich) 2021;23:309-16. [PMID: 33340251 DOI: 10.1111/jch.14138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 AlAnizy L, AlMatham K, Al Basheer A, AlFayyad I. Complementary and Alternative Medicine Practice Among Saudi Patients with Chronic Kidney Disease: A Cross-Sectional Study. Int J Nephrol Renovasc Dis 2020;13:11-8. [PMID: 32099440 DOI: 10.2147/IJNRD.S240705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Li J, Wang Y, Xu X, Cao W, Shen Z, Wang N, Leng J, Zou N, Shang E, Zhu Z, Guo J, Duan J. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids. Phytomedicine 2019;57:166-73. [PMID: 30772752 DOI: 10.1016/j.phymed.2018.12.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
26 Avramovic M, Stefanovic V. Health-Related Quality of Life in Different Stages of Renal Failure: HRQoL IN PATIENTS WITH RENAL FAILURE. Artificial Organs 2012;36:581-9. [DOI: 10.1111/j.1525-1594.2011.01429.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
27 Lee H, Oh YJ, Kim M, Kim H, Lee JP, Kim S, Oh KH, Jun Chin H, Joo KW, Lim CS, Kim S, Kim YS, Kim DK. The association of moderate renal dysfunction with impaired preference-based health-related quality of life: third Korean national health and nutritional examination survey. BMC Nephrol 2012;13:19. [PMID: 22530944 DOI: 10.1186/1471-2369-13-19] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
28 McClellan WM, Abramson J, Newsome B, Temple E, Wadley VG, Audhya P, McClure LA, Howard VJ, Warnock DG, Kimmel P. Physical and psychological burden of chronic kidney disease among older adults. Am J Nephrol 2010;31:309-17. [PMID: 20164652 DOI: 10.1159/000285113] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
29 Potok OA, Nguyen HA, Abdelmalek JA, Beben T, Woodell TB, Rifkin DE. Patients,' Nephrologists,' and Predicted Estimations of ESKD Risk Compared with 2-Year Incidence of ESKD. Clin J Am Soc Nephrol 2019;14:206-12. [PMID: 30630859 DOI: 10.2215/CJN.07970718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
30 Alavi N, Aliakbarzadeh Z, Sharifi K. Depression, Anxiety, Activities of Daily Living, and Quality of Life Scores in Patients Undergoing Renal Replacement Therapies. Transplantation Proceedings 2009;41:3693-6. [DOI: 10.1016/j.transproceed.2009.06.217] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
31 Noda Y, Ito K, Kanki A, Tamada T, Yamamoto A, Kazuya Y, Higaki A. Measurement of renal cortical thickness using noncontrast-enhanced steady-state free precession MRI with spatially selective inversion recovery pulse: Association with renal function: Renal Function Evaluation with MRI. J Magn Reson Imaging 2015;41:1615-21. [DOI: 10.1002/jmri.24719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
32 Sulowicz W, Locatelli F, Ryckelynck J, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U. Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly. CJASN 2007;2:637-46. [DOI: 10.2215/cjn.03631006] [Cited by in Crossref: 104] [Cited by in F6Publishing: 30] [Article Influence: 6.9] [Reference Citation Analysis]
33 Kop WJ, Seliger SL, Fink JC, Katz R, Odden MC, Fried LF, Rifkin DE, Sarnak MJ, Gottdiener JS. Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. Clin J Am Soc Nephrol 2011;6:834-44. [PMID: 21393483 DOI: 10.2215/CJN.03840510] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
34 Fraser S, Taal M. Helping people to live well with chronic kidney disease. Br J Hosp Med 2020;81:1-10. [DOI: 10.12968/hmed.2020.0069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Gozdowska J, Zatorski M, Torchalla P, Białek Ł, Bojanowska A, Tomaszek A, Serwańska-Świętek M, Kieszek R, Kwiatkowski A, Chmura A, Durlik M. Living-Donor Versus Deceased-Donor Kidney Transplantation: Comparison of Psychosocial Consequences for Recipients. Transplant Proc 2016;48:1498-505. [PMID: 27496435 DOI: 10.1016/j.transproceed.2016.01.075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
36 Oh TR, Choi HS, Suh SH, Kim CS, Bae EH, Sung S, Han SH, Oh KH, Ma SK, Kim SW. The Association between Health-Enhancing Physical Activity and Quality of Life in Patients with Chronic Kidney Disease: Propensity Score Matching Analysis. IJERPH 2022;19:1318. [DOI: 10.3390/ijerph19031318] [Reference Citation Analysis]
37 Yen M, Huang J, Teng H. Education for patients with chronic kidney disease in Taiwan: a prospective repeated measures study. Journal of Clinical Nursing 2008;17:2927-34. [DOI: 10.1111/j.1365-2702.2008.02348.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
38 Sadeghi Shad J, Akbari R, Qujeq D, Hajian-Tilaki K. Measurement of serum irisin in the different stages of chronic kidney disease. Caspian J Intern Med 2019;10:314-9. [PMID: 31558994 DOI: 10.22088/cjim.10.3.314] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Ibrahim AA, Althomali OW, Atyia MR, Hussein HM, Abdelbasset WK, Eldesoky MTM, Gamal M. A systematic review of trials investigating the efficacy of exercise training for functional capacity and quality of life in chronic kidney disease patients. Int Urol Nephrol 2021. [PMID: 34146218 DOI: 10.1007/s11255-021-02917-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Cloyd JM, Ma Y, Morton JM, Kurella Tamura M, Poultsides GA, Visser BC. Does chronic kidney disease affect outcomes after major abdominal surgery? J Gastrointest Surg. 2014;18:605-612. [PMID: 24241964 DOI: 10.1007/s11605-013-2390-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
41 Hiragi S, Yamada H, Tsukamoto T, Yoshida K, Kondo N, Matsubara T, Yanagita M, Tamura H, Kuroda T. Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study. Clin Epidemiol 2018;10:265-76. [PMID: 29563839 DOI: 10.2147/CLEP.S158110] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Curtin RB, Walters BA, Schatell D, Pennell P, Wise M, Klicko K. Self-Efficacy and Self-Management Behaviors in Patients With Chronic Kidney Disease. Advances in Chronic Kidney Disease 2008;15:191-205. [DOI: 10.1053/j.ackd.2008.01.006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 7.5] [Reference Citation Analysis]
43 Modi GK, Yadav AK, Ghosh A, Kamboj K, Kaur P, Kumar V, Bhansali S, Prasad N, Sahay M, Parameswaran S, Varughese S, Gang S, Singh S, Sircar D, Gopalakrishnan N, Jaryal A, Vikrant S, Baid-Agrawal S, Jha V. Nonmedical Factors and Health-Related Quality of Life in CKD in India. Clin J Am Soc Nephrol 2020;15:191-9. [PMID: 32001488 DOI: 10.2215/CJN.06510619] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Liang S, Wang WL, Zhu FL, Duan SW, Sun XF, Chen XM, Cai GY; Chinese observational prospective study of ageing population with chronic kidney disease (C-OPTION). Chinese observational prospective study of ageing population with chronic kidney disease (C-OPTION): a study protocol. BMJ Open 2018;8:e019457. [PMID: 29478020 DOI: 10.1136/bmjopen-2017-019457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Cruz MC, Andrade C, Urrutia M, Draibe S, Nogueira-Martins LA, Sesso Rde C. Quality of life in patients with chronic kidney disease. Clinics (Sao Paulo) 2011;66:991-5. [PMID: 21808864 DOI: 10.1590/s1807-59322011000600012] [Cited by in Crossref: 90] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
46 Tajima R, Kondo M, Kai H, Saito C, Okada M, Takahashi H, Doi M, Tsuruoka S, Yamagata K. Measurement of health-related quality of life in patients with chronic kidney disease in Japan with EuroQol (EQ-5D). Clin Exp Nephrol 2010;14:340-8. [PMID: 20567874 DOI: 10.1007/s10157-010-0304-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
47 Reilly-Spong M, Reibel D, Pearson T, Koppa P, Gross CR. Telephone-adapted mindfulness-based stress reduction (tMBSR) for patients awaiting kidney transplantation: Trial design, rationale and feasibility. Contemp Clin Trials 2015;42:169-84. [PMID: 25847578 DOI: 10.1016/j.cct.2015.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
48 Tannor EK, Norman BR, Adusei KK, Sarfo FS, Davids MR, Bedu-Addo G. Quality of life among patients with moderate to advanced chronic kidney disease in Ghana - a single centre study. BMC Nephrol 2019;20:122. [PMID: 30961570 DOI: 10.1186/s12882-019-1316-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
49 Porter AC, Lash JP, Xie D, Pan Q, DeLuca J, Kanthety R, Kusek JW, Lora CM, Nessel L, Ricardo AC, Wright Nunes J, Fischer MJ; CRIC Study Investigators. Predictors and Outcomes of Health-Related Quality of Life in Adults with CKD. Clin J Am Soc Nephrol 2016;11:1154-62. [PMID: 27246012 DOI: 10.2215/CJN.09990915] [Cited by in Crossref: 60] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
50 Seidel UK, Gronewold J, Volsek M, Todica O, Kribben A, Bruck H, Hermann DM. Physical, cognitive and emotional factors contributing to quality of life, functional health and participation in community dwelling in chronic kidney disease. PLoS One 2014;9:e91176. [PMID: 24614180 DOI: 10.1371/journal.pone.0091176] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
51 Yoshizaki T, Naganuma T, Kobayashi T, Horikoshi T, Onishi H, Kawamoto H, Nakamura S, Nakamura S. Long-term follow-up of first generation versus new-generation drug-eluting stents in three-vessel coronary artery disease. Cardiovascular Revascularization Medicine 2017;18:492-6. [DOI: 10.1016/j.carrev.2017.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Razzera BN, Adamoli AN, Ranheiri MF, Oliveira MDS, Feoli AMP. Impacts of mindfulness-based interventions in people undergoing hemodialysis: a systematic review. J Bras Nefrol 2021:S0101-28002021005070301. [PMID: 34643641 DOI: 10.1590/2175-8239-JBN-2021-0116] [Reference Citation Analysis]
53 Vero LM, Byham-gray L, Parrott JS, Steiber AL. Use of the Subjective Global Assessment to Predict Health-Related Quality of Life in Chronic Kidney Disease Stage 5 Patients on Maintenance Hemodialysis. Journal of Renal Nutrition 2013;23:141-7. [DOI: 10.1053/j.jrn.2012.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
54 Grady KL, Fazeli PL, Kirklin JK, Pamboukian SV, White-Williams C. Factors Associated With Health-Related Quality of Life 2 Years After Left Ventricular Assist Device Implantation: Insights From INTERMACS. J Am Heart Assoc 2021;10:e021196. [PMID: 34238018 DOI: 10.1161/JAHA.121.021196] [Reference Citation Analysis]
55 Agarwal AK, Silver MR, Reed JE, Dhingra RK, Liu W, Varma N, Stehman-breen C. An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis. J Intern Med 2006;260:577-85. [DOI: 10.1111/j.1365-2796.2006.01723.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
56 Chen C, Tsai Y, Hsu H, Wu I, Sun C, Chou C, Lee C, Tsai C, Wu M, Wang L. Depression and Suicide Risk in Hemodialysis Patients With Chronic Renal Failure. Psychosomatics 2010;51:528-528.e6. [DOI: 10.1016/s0033-3182(10)70747-7] [Cited by in Crossref: 71] [Article Influence: 5.9] [Reference Citation Analysis]
57 Pham PC, Toscano E, Pham PM, Pham PA, Pham SV, Pham PT. Pain management in patients with chronic kidney disease. NDT Plus 2009;2:111-8. [PMID: 25949305 DOI: 10.1093/ndtplus/sfp001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
58 Myint TM, O'shaughnessy DV, Marshall S, Vucak-dzumhur M, Elder GJ. Health-related quality of life of patients awaiting kidney and simultaneous pancreas-kidney transplants: Quality of life in patients awaiting transplantation. Nephrology 2013;18:827-32. [DOI: 10.1111/nep.12160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
59 Oleru OO, Shah NV, Zhou PL, Sedaghatpour D, Mistry JB, Wham BC, Kurtzman J, Mithani SK, Koehler SM. Recent Smoking History Is Not Associated With Adverse 30-Day Standardized Postoperative Outcomes Following Microsurgical Reconstructive Procedures of the Upper Extremity. Plast Surg (Oakv). [DOI: 10.1177/22925503211024755] [Reference Citation Analysis]
60 Rottembourg J, Tilleul P, Deray G, Lafuma A, Zakin L, Mahi L, Wernli J. Cost of managing anemia in end-stage renal disease: the experience of five French dialysis centers. Eur J Health Econ 2015;16:357-64. [PMID: 24570298 DOI: 10.1007/s10198-014-0571-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Goh KKK, Lai PSM, Lim SK. Cross cultural adaptation and validation of the Malay Kidney Disease Quality of Life (KDQOL-36™). BMC Nephrol 2019;20:226. [PMID: 31221116 DOI: 10.1186/s12882-019-1397-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Fitschen PJ, Biruete A, Jeong J, Wilund KR. Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in maintenance hemodialysis patients: HMB supplementation in hemodialysis patients. Hemodialysis International 2017;21:107-16. [DOI: 10.1111/hdi.12440] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
63 Pagels AA, Söderkvist BK, Medin C, Hylander B, Heiwe S. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual Life Outcomes. 2012;10:71. [PMID: 22710013 DOI: 10.1186/1477-7525-10-71] [Cited by in Crossref: 103] [Cited by in F6Publishing: 88] [Article Influence: 10.3] [Reference Citation Analysis]
64 Spinowitz B, Coyne DW, Lok CE, Fraticelli M, Azer M, Dalal S, Villa G, Rosansky S, Adamis H, Beyer U. C.E.R.A. Maintains Stable Control of Hemoglobin in Patients with Chronic Kidney Disease on Dialysis when Administered Once Every Two Weeks. Am J Nephrol 2008;28:280-9. [DOI: 10.1159/000111115] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
65 Park JI, Baek H, Jung HH. CKD and Health-Related Quality of Life: The Korea National Health and Nutrition Examination Survey. American Journal of Kidney Diseases 2016;67:851-60. [DOI: 10.1053/j.ajkd.2015.11.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
66 Arjuna Rao AS, Phaneendra D, Pavani ChD, Soundararajan P, Rani NV, Thennarasu P, Kannan G. Usage of complementary and alternative medicine among patients with chronic kidney disease on maintenance hemodialysis. J Pharm Bioallied Sci 2016;8:52-7. [PMID: 26957870 DOI: 10.4103/0975-7406.171692] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
67 Neijenhuis MK, Kievit W, Perrone RD, Sloan JA, Erwin P, Murad MH, Gevers TJG, Hogan MC, Drenth JPH. The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression. BMC Nephrol 2017;18:169. [PMID: 28545401 DOI: 10.1186/s12882-017-0578-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
68 Rodrigue JR, Mandelbrot DA, Pavlakis M. A psychological intervention to improve quality of life and reduce psychological distress in adults awaiting kidney transplantation. Nephrol Dial Transplant 2011;26:709-15. [PMID: 20603243 DOI: 10.1093/ndt/gfq382] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
69 Lee SJ, Son H. Comparison of health-related quality of life between patients with stage 3 and 4 chronic kidney disease and patients undergoing continuous ambulatory peritoneal dialysis. Jpn J Nurs Sci 2016;13:166-73. [PMID: 26542889 DOI: 10.1111/jjns.12101] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Senevirathna L, Abeysekera T, Nanayakkara S, Chandrajith R, Ratnatunga N, Harada KH, Hitomi T, Komiya T, Muso E, Koizumi A. Risk factors associated with disease progression and mortality in chronic kidney disease of uncertain etiology: a cohort study in Medawachchiya, Sri Lanka. Environ Health Prev Med 2012;17:191-8. [PMID: 21881957 DOI: 10.1007/s12199-011-0237-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
71 Han Y, Balkrishnan R, Hirth RA, Hutton DW, He K, Steffick DE, Saran R. Assessment of Prescription Analgesic Use in Older Adults With and Without Chronic Kidney Disease and Outcomes. JAMA Netw Open 2020;3:e2016839. [PMID: 32997126 DOI: 10.1001/jamanetworkopen.2020.16839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
72 Hansen RA, Chin H, Blalock S, Joy MS. Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care. Res Social Adm Pharm 2009;5:143-53. [PMID: 19524862 DOI: 10.1016/j.sapharm.2008.06.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
73 Finkelstein FO, Story K, Firanek C, Mendelssohn D, Barre P, Takano T, Soroka S, Mujais S. Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am Soc Nephrol 2009;4:33-8. [PMID: 18987300 DOI: 10.2215/CJN.00630208] [Cited by in Crossref: 89] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
74 Hoshino J, Muenz D, Zee J, Sukul N, Speyer E, Guedes M, Lopes AA, Asahi K, van Haalen H, James G, Dhalwani N, Pecoits-filho R, Bieber B, Robinson BM, Pisoni RL, Lopes A, Pecoits-filho R, Combe C, Jacquelinet C, Massy Z, Stengel B, Duttlinger J, Fliser D, Lonnemann G, Reichel H, Wada T, Yamagata K, Pisoni R, Robinson B, Calice da Silva V, Sesso R, Speyer E, Asahi K, Hoshino J, Narita I, Perlman R, Port F, Sukul N, Wong M, Young E, Zee J. Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD. Journal of Renal Nutrition 2020;30:404-14. [DOI: 10.1053/j.jrn.2019.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
75 Bagherniya M, Soleimani D, Rouhani MH, Askari G, Sathyapalan T, Sahebkar A. The Use of Curcumin for the Treatment of Renal Disorders: A Systematic Review of Randomized Controlled Trials. Adv Exp Med Biol 2021;1291:327-43. [PMID: 34331699 DOI: 10.1007/978-3-030-56153-6_19] [Reference Citation Analysis]
76 Hussien H, Apetrii M, Covic A. Health-related quality of life in patients with chronic kidney disease. Expert Rev Pharmacoecon Outcomes Res 2021;21:43-54. [PMID: 33213186 DOI: 10.1080/14737167.2021.1854091] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Naser AY, Alwafi H, Alotaibi B, Salawati E, Samannodi M, Alsairafi Z, Alanazi AFR, Dairi MS. Prevalence of Chronic Kidney Diseases in Patients with Diabetes Mellitus in the Middle East: A Systematic Review and Meta-Analysis. Int J Endocrinol 2021;2021:4572743. [PMID: 34497644 DOI: 10.1155/2021/4572743] [Reference Citation Analysis]
78 Seth AK, De la Garza M, Fang RC, Hong SJ, Galiano RD. Excisional wound healing is delayed in a murine model of chronic kidney disease. PLoS One 2013;8:e59979. [PMID: 23536900 DOI: 10.1371/journal.pone.0059979] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
79 Finkelstein FO, Wuerth D, Finkelstein SH. Health related quality of life and the CKD patient: challenges for the nephrology community. Kidney International 2009;76:946-52. [DOI: 10.1038/ki.2009.307] [Cited by in Crossref: 120] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
80 Grimaldi V, Sommese L, Picascia A, Casamassimi A, Cacciatore F, Renda A, De Rosa P, Montesano ML, Sabia C, Fiorito C, De Iorio G, Napoli C. Association between human leukocyte antigen class I and II alleles and hepatitis C virus infection in high-risk hemodialysis patients awaiting kidney transplantation. Hum Immunol 2013;74:1629-32. [PMID: 23974050 DOI: 10.1016/j.humimm.2013.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
81 Tander B, Akpolat T, Durmus D, Canturk F. Evaluation of Hand Functions in Hemodialysis Patients. Renal Failure 2009;29:477-80. [DOI: 10.1080/08860220701268167] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
82 Esmaeilizadeh Z, Mohammadi B, Rajabibazl M, Ghaderian SMH, Omrani MD, Fazeli Z. Expression Analysis of GDNF/RET Signaling Pathway in Human AD-MSCs Grown in HEK 293 Conditioned Medium (HEK293-CM). Cell Biochem Biophys 2020;78:531-9. [PMID: 32803668 DOI: 10.1007/s12013-020-00936-z] [Reference Citation Analysis]
83 Birmelé B, Le Gall A, Sautenet B, Aguerre C, Camus V. Clinical, sociodemographic, and psychological correlates of health-related quality of life in chronic hemodialysis patients. Psychosomatics 2012;53:30-7. [PMID: 22221719 DOI: 10.1016/j.psym.2011.07.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
84 Lin MY, Liu MF, Hsu LF, Tsai PS. Effects of self-management on chronic kidney disease: A meta-analysis. Int J Nurs Stud 2017;74:128-37. [PMID: 28689160 DOI: 10.1016/j.ijnurstu.2017.06.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
85 Zegarow P, Manczak M, Rysz J, Olszewski R. The influence of cognitive-behavioral therapy on depression in dialysis patients - meta-analysis. Arch Med Sci 2020;16:1271-8. [PMID: 33224325 DOI: 10.5114/aoms.2019.88019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Varan C, Anceschi A, Sevli S, Bruni N, Giraudo L, Bilgiç E, Korkusuz P, İskit AB, Trotta F, Bilensoy E. Preparation and characterization of cyclodextrin nanosponges for organic toxic molecule removal. Int J Pharm 2020;585:119485. [PMID: 32497732 DOI: 10.1016/j.ijpharm.2020.119485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
87 Rasu RS, Crawford T, Manley HJ, Balkrishnan R. Treatment of hypertension and diabetes mellitus in patients with chronic kidney disease: a review. Expert Opin Pharmacother 2007;8:2543-51. [PMID: 17931089 DOI: 10.1517/14656566.8.15.2543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
88 Yoshikawa T, Nomi T, Hokuto D, Kamitani N, Matsuo Y, Sho M. Outcomes in Patients with Chronic Kidney Disease After Liver Resection for Hepatocellular Carcinoma. World J Surg 2021;45:598-606. [PMID: 33089346 DOI: 10.1007/s00268-020-05829-z] [Reference Citation Analysis]
89 Iwasaki M, Borgnakke WS, Awano S, Yoshida A, Hamasaki T, Teratani G, Kataoka S, Kakuta S, Soh I, Ansai T, Nakamura H. Periodontitis and health-related quality of life in hemodialysis patients. Clin Exp Dent Res 2017;3:13-8. [PMID: 29744174 DOI: 10.1002/cre2.50] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
90 Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Greene T, Hiremath L, Kendrick C, Kusek JW, Thornley-Brown D, Wang X, Norris K, Unruh M, Lash J. Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease. Transl Res 2012;159:4-11. [PMID: 22153804 DOI: 10.1016/j.trsl.2011.09.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
91 Bajaj S, Makkar BM, Abichandani VK, Talwalkar PG, Saboo B, Srikanta SS, Das A, Chandrasekaran S, Krishnan PV, Shah A, Abraham G, Tikku P, Kumar S. Management of anemia in patients with diabetic kidney disease: A consensus statement. Indian J Endocrinol Metab 2016;20:268-81. [PMID: 27042425 DOI: 10.4103/2230-8210.176348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
92 Abeywickrama HM, Wimalasiri S, Koyama Y, Uchiyama M, Shimizu U, Kakihara N, Chandrajith R, Nanayakkara N. Quality of Life and Symptom Burden among Chronic Kidney Disease of Uncertain Etiology (CKDu) Patients in Girandurukotte, Sri Lanka. Int J Environ Res Public Health 2020;17:E4041. [PMID: 32517110 DOI: 10.3390/ijerph17114041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
93 Toyama T, van den Broek-best O, Ohkuma T, Handelsman D, Waite LM, Seibel MJ, Cumming R, Naganathan V, Sherrington C, Hirani V, Wang AY, Newman A. Associations of Impaired Renal Function With Declines in Muscle Strength and Muscle Function in Older Men: Findings From the CHAMP Study. The Journals of Gerontology: Series A 2019;74:1812-20. [DOI: 10.1093/gerona/glz100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
94 Kim JY, Lee S, Cha J, Son G, Kim DK. Chronic kidney disease is associated with increased risk of sudden sensorineural hearing loss and Ménière's disease: a nationwide cohort study. Sci Rep 2021;11:20194. [PMID: 34642430 DOI: 10.1038/s41598-021-99792-x] [Reference Citation Analysis]
95 Jhee JH, Lee E, Cha MU, Lee M, Kim H, Park S, Yun HR, Jung SY, Kee YK, Yoon CY, Han SH, Yoo TH, Kang SW, Park JT. Prevalence of depression and suicidal ideation increases proportionally with renal function decline, beginning from early stages of chronic kidney disease. Medicine (Baltimore) 2017;96:e8476. [PMID: 29095304 DOI: 10.1097/MD.0000000000008476] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
96 Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. The Lancet 2007;369:381-8. [DOI: 10.1016/s0140-6736(07)60194-9] [Cited by in Crossref: 439] [Cited by in F6Publishing: 122] [Article Influence: 29.3] [Reference Citation Analysis]
97 Viggiano D, Wagner CA, Blankestijn PJ, Bruchfeld A, Fliser D, Fouque D, Frische S, Gesualdo L, Gutiérrez E, Goumenos D, Hoorn EJ, Eckardt KU, Knauß S, König M, Malyszko J, Massy Z, Nitsch D, Pesce F, Rychlík I, Soler MJ, Spasovski G, Stevens KI, Trepiccione F, Wanner C, Wiecek A, Zoccali C, Unwin R, Capasso G. Mild cognitive impairment and kidney disease: clinical aspects. Nephrol Dial Transplant 2020;35:10-7. [PMID: 31071220 DOI: 10.1093/ndt/gfz051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
98 Bowles NP, Thosar SS, Herzig MX, Shea SA. Chronotherapy for Hypertension. Curr Hypertens Rep 2018;20:97. [PMID: 30267334 DOI: 10.1007/s11906-018-0897-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
99 Broers NJH, Martens RJH, Canaud B, Cornelis T, Dejagere T, Diederen NMP, Hermans MMH, Konings CJAM, Stifft F, Wirtz JJJM, Leunissen KML, van der Sande FM, Kooman JP. Health-related quality of life in end-stage renal disease patients: the effects of starting dialysis in the first year after the transition period. Int Urol Nephrol 2018;50:1131-42. [PMID: 29582338 DOI: 10.1007/s11255-018-1845-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
100 de Goeij MC, Ocak G, Rotmans JI, Eijgenraam JW, Dekker FW, Halbesma N. Course of symptoms and health-related quality of life during specialized pre-dialysis care. PLoS One 2014;9:e93069. [PMID: 24699666 DOI: 10.1371/journal.pone.0093069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
101 Spiegel BM, Melmed G, Robbins S, Esrailian E. Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol. 2008;3:1759-1768. [PMID: 18832106 DOI: 10.2215/cjn.00820208] [Cited by in Crossref: 78] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
102 Schweitzer ML, Stengel B, Legrand K, Briançon S, Jacquelinet C, Combe C, Fouque D, Massy ZA, Laville M, Frimat L, Ayav C. Obesity phenotype and patient-reported outcomes in moderate and severe chronic kidney disease: a cross-sectional study from the CKD-REIN cohort study. Qual Life Res 2019;28:1873-83. [DOI: 10.1007/s11136-019-02110-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
103 Wong MG, Ninomiya T, Liyanage T, Sukkar L, Hirakawa Y, Wang Y, Wyld MLR, Morton RL, Chadban S, Howard K, Jardine MJ. Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis. Nephrology (Carlton) 2019;24:605-14. [PMID: 30039893 DOI: 10.1111/nep.13445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
104 Fukuma S, Ikenoue T, Shimizu S, Norton EC, Saran R, Yanagita M, Kato G, Nakayama T, Fukuhara S; and on behalf of BiDANE: Big Data Analysis of Medical Care for the Older in Kyoto. Quality of Care in Chronic Kidney Disease and Incidence of End-stage Renal Disease in Older Patients: A Cohort Study. Med Care 2020;58:625-31. [PMID: 31985583 DOI: 10.1097/MLR.0000000000001301] [Reference Citation Analysis]
105 Tannor EK, Archer E, Kapembwa K, van Schalkwyk SC, Davids MR. Quality of life in patients on chronic dialysis in South Africa: a comparative mixed methods study. BMC Nephrol 2017;18:4. [PMID: 28056851 DOI: 10.1186/s12882-016-0425-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
106 De Francisco ALM, Sulowicz W, Klinger M, Niemczyk S, Vargemezis V, Metivier F, Dougherty FC, Oguey D; ON BEHALF OF THE BA16260 STUDY INVESTIGATORS. Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study: C.E.R.A. CORRECTS ANAEMIA IN PATIENTS WITH CKD. International Journal of Clinical Practice 2006;60:1687-96. [DOI: 10.1111/j.1742-1241.2006.01214.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
107 Artzi-Medvedik R, Kob R, Fabbietti P, Lattanzio F, Corsonello A, Melzer Y, Roller-Wirnsberger R, Wirnsberger G, Mattace-Raso F, Tap L, Gil P, Martinez SL, Formiga F, Moreno-González R, Kostka T, Guligowska A, Ärnlöv J, Carlsson AC, Freiberger E, Melzer I; SCOPE investigators. Impaired kidney function is associated with lower quality of life among community-dwelling older adults : The screening for CKD among older people across Europe (SCOPE) study. BMC Geriatr 2020;20:340. [PMID: 33008306 DOI: 10.1186/s12877-020-01697-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Bonner A, Wellard S, Caltabiano M. The impact of fatigue on daily activity in people with chronic kidney disease: The impact of fatigue on daily activity in people. Journal of Clinical Nursing 2010;19:3006-15. [DOI: 10.1111/j.1365-2702.2010.03381.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
109 Nandula SR, Kundu N, Awal HB, Brichacek B, Fakhri M, Aimalla N, Elzarki A, Amdur RL, Sen S. Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes. Cardiovasc Diabetol 2021;20:44. [PMID: 33581737 DOI: 10.1186/s12933-021-01235-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Tsai YC, Hung CC, Hwang SJ, Wang SL, Hsiao SM, Lin MY, Kung LF, Hsiao PN, Chen HC. Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease. Nephrology Dialysis Transplantation 2010;25:1621-6. [DOI: 10.1093/ndt/gfp671] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
111 Thaweethamcharoen T, Sakulbumrungsil R, Nopmaneejumruslers C, Vasuvattakul S. Cost-Utility Analysis of Erythropoietin for Anemia Treatment in Thai End-Stage Renal Disease Patients with Hemodialysis. Value in Health Regional Issues 2014;3:44-9. [DOI: 10.1016/j.vhri.2014.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
112 Harhay MN, Yang W, Sha D, Roy J, Chai B, Fischer MJ, Hamm LL, Hart PD, Hsu CY, Huan Y, Huml AM, Kallem RR, Tamura MK, Porter AC, Ricardo AC, Slaven A, Rosas SE, Townsend RR, Reese PP, Lash JP, Akkina S; CRIC Study Investigators. Health-Related Quality of Life, Depressive Symptoms, and Kidney Transplant Access in Advanced CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Kidney Med 2020;2:600-609.e1. [PMID: 33089138 DOI: 10.1016/j.xkme.2020.06.010] [Reference Citation Analysis]
113 Pagels AA, Stendahl M, Evans M. Patient-reported outcome measures as a new application in the Swedish Renal Registry: health-related quality of life through RAND-36. Clin Kidney J 2020;13:442-9. [PMID: 32699625 DOI: 10.1093/ckj/sfz084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
114 Lee W, Prifti K, Kim H, Kim E, Yang J, Min J, Park JY, Kim YC, Lee JP, Bell ML. Short-term Exposure to Air Pollution and Attributable Risk of Kidney Diseases: A Nationwide Time-series Study. Epidemiology 2022;33:17-24. [PMID: 34711735 DOI: 10.1097/EDE.0000000000001430] [Reference Citation Analysis]
115 Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016;11:e0158765. [PMID: 27383068 DOI: 10.1371/journal.pone.0158765] [Cited by in Crossref: 1118] [Cited by in F6Publishing: 993] [Article Influence: 186.3] [Reference Citation Analysis]
116 Friedman AJ, Shander A, Martin SR, Calabrese RK, Ashton ME, Lew I, Seid MH, Goodnough LT. Iron Deficiency Anemia in Women: A Practical Guide to Detection, Diagnosis, and Treatment. Obstetrical & Gynecological Survey 2015;70:342-53. [DOI: 10.1097/ogx.0000000000000172] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
117 Fraser SD, Taal MW. Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment. Curr Opin Nephrol Hypertens 2016;25:465-72. [PMID: 27490909 DOI: 10.1097/MNH.0000000000000270] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
118 Ramer SJ, McCall NN, Robinson-Cohen C, Siew ED, Salat H, Bian A, Stewart TG, El-Sourady MH, Karlekar M, Lipworth L, Ikizler TA, Abdel-Kader K. Health Outcome Priorities of Older Adults with Advanced CKD and Concordance with Their Nephrology Providers' Perceptions. J Am Soc Nephrol 2018;29:2870-8. [PMID: 30385652 DOI: 10.1681/ASN.2018060657] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
119 Kim JH, Han JM, Kim H, Lee KB, Chung W, Kim YS, Park SK, Chae DW, Ahn C, Oh KH, Hyun YY; KNOW-CKD Study Group. Low serum adiponectin level is associated with better physical health-related quality of life in chronic kidney disease. Sci Rep 2021;11:10928. [PMID: 34035377 DOI: 10.1038/s41598-021-90339-8] [Reference Citation Analysis]
120 Tang YS, Zhao YH, Zhong Y, Li XZ, Pu JX, Luo YC, Zhou QL. Neferine inhibits LPS-ATP-induced endothelial cell pyroptosis via regulation of ROS/NLRP3/Caspase-1 signaling pathway. Inflamm Res 2019;68:727-38. [PMID: 31172209 DOI: 10.1007/s00011-019-01256-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
121 Fukuhara S, Yamazaki S, Marumo F, Akiba T, Akizawa T, Fujimi S, Haruki S, Kawaguchi Y, Nihei H, Shoji T, Maeda T. Health-Related Quality of Life of Predialysis Patients with Chronic Renal Failure. Nephron Clin Pract 2006;105:c1-8. [DOI: 10.1159/000096802] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
122 Sohn BK, Oh YK, Choi JS, Song J, Lim A, Lee JP, An JN, Choi HJ, Hwang JY, Jung HY, Lee JY, Lim CS. Effectiveness of group cognitive behavioral therapy with mindfulness in end-stage renal disease hemodialysis patients. Kidney Res Clin Pract 2018;37:77-84. [PMID: 29629280 DOI: 10.23876/j.krcp.2018.37.1.77] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
123 Hill NR, Lasserson D, Fatoba S, O'Callaghan CA, Pugh C, Perera-Salazar R, Shine B, Thompson B, Wolstenholme J, McManus R, Hobbs FD. The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK. BMJ Open 2013;3:e004265. [PMID: 24345903 DOI: 10.1136/bmjopen-2013-004265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
124 Goh SG, Rusli BN, Khalid BA. Diabetes quality of life perception in a multiethnic population. Qual Life Res. 2015;24:1677-1686. [PMID: 25492728 DOI: 10.1007/s11136-014-0885-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
125 Disney A, Jersey PD, Kirkland G, Mantha M, Charlesworth JA, Gallagher M, Harris D, Gock H, Mangos GJ, Macmillan J, Liu W, Viswalingam A. Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: A multicentre, open-label, Australian study. Nephrology 2007;12:95-101. [DOI: 10.1111/j.1440-1797.2006.00757.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
126 Kelley K, Aricak OT, Light RP, Agarwal R. Proteinuria is a determinant of quality of life in diabetic nephropathy: modeling lagged effects with path analysis. Am J Nephrol 2007;27:488-94. [PMID: 17664865 DOI: 10.1159/000106672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
127 Bonner A, Wellard S, Caltabiano M. Determining patient activity levels in chronic kidney disease. Journal of Nursing and Healthcare of Chronic Illness 2009;1:39-48. [DOI: 10.1111/j.1365-2702.2008.01002.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
128 Kooman JP, van der Sande FM, Leunissen KM. Kidney disease and aging: A reciprocal relation. Experimental Gerontology 2017;87:156-9. [DOI: 10.1016/j.exger.2016.02.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
129 Libório AB, Santos JP, Minete NF, Diógenes Cde A, Soares AP, Queiroz AL, Barreto DM. Proteinuria is associated with quality of life and depression in adults with primary glomerulopathy and preserved renal function. PLoS One 2012;7:e37763. [PMID: 22662214 DOI: 10.1371/journal.pone.0037763] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
130 Gross CR, Reilly-Spong M, Park T, Zhao R, Gurvich OV, Ibrahim HN. Telephone-adapted Mindfulness-based Stress Reduction (tMBSR) for patients awaiting kidney transplantation. Contemp Clin Trials 2017;57:37-43. [PMID: 28342990 DOI: 10.1016/j.cct.2017.03.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
131 Tong A, Lesmana B, Johnson DW, Wong G, Campbell D, Craig JC. The perspectives of adults living with peritoneal dialysis: thematic synthesis of qualitative studies. Am J Kidney Dis 2013;61:873-88. [PMID: 23177729 DOI: 10.1053/j.ajkd.2012.08.045] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
132 Ikonomou M, Skapinakis P, Balafa O, Eleftheroudi M, Damigos D, Siamopoulos KC. THE IMPACT OF SOCIOECONOMIC FACTORS ON QUALITY OF LIFE OF PATIENTS WITH CHRONIC KIDNEY DISEASE IN GREECE. J Ren Care 2015;41:239-46. [PMID: 26119629 DOI: 10.1111/jorc.12132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
133 Kimura H, Sy J, Okuda Y, Wenziger C, Hanna R, Obi Y, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Streja E. A faster decline of residual kidney function and erythropoietin stimulating agent hyporesponsiveness in incident hemodialysis patients. Hemodial Int 2021;25:60-70. [PMID: 33034069 DOI: 10.1111/hdi.12877] [Reference Citation Analysis]
134 Kadowaki D, Sumikawa S, Arimizu K, Taguchi K, Kitamura K, Ishitsuka Y, Narita Y, Irie T, Chuang VTG, Maruyama T, Otagiri M, Hirata S. Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats. Life Sciences 2012;91:1304-8. [DOI: 10.1016/j.lfs.2012.09.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
135 González MT, Ramos R, Vera M, Barbosa F, Garcia C, Garcia I, González-Segura C, Cuxart M, Teixidó J, José de la Cruz J. Monthly CERA treatment maintains stable hemoglobin levels in routine clinical practice of peritoneal dialysis patients. Ren Fail 2013;35:314-9. [PMID: 23356501 DOI: 10.3109/0886022X.2012.755903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
136 Mujais SK, Story K, Brouillette J, Takano T, Soroka S, Franek C, Mendelssohn D, Finkelstein FO. Health-related quality of life in CKD Patients: correlates and evolution over time. Clin J Am Soc Nephrol 2009;4:1293-301. [PMID: 19643926 DOI: 10.2215/CJN.05541008] [Cited by in Crossref: 141] [Cited by in F6Publishing: 90] [Article Influence: 10.8] [Reference Citation Analysis]
137 Vasilieva IA. Quality of life in chronic hemodialysis patients in Russia. Hemodialysis Int 2006;10:274-8. [DOI: 10.1111/j.1542-4758.2006.00108.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
138 Remuzzi G, Minetti L, Schieppati A. Treatment of Anemia and Bleeding in Chronic Kidney Disease. Therapy in Nephrology & Hypertension. Elsevier; 2008. pp. 756-64. [DOI: 10.1016/b978-141605484-9.50070-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
139 Elisabeth Stømer U, Klopstad Wahl A, Gunnar Gøransson L, Hjorthaug Urstad K. Health Literacy in Kidney Disease: Associations with Quality of Life and Adherence. Journal of Renal Care 2020;46:85-94. [DOI: 10.1111/jorc.12314] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
140 Kerr PG. Renal anaemia: recent developments, innovative approaches and future directions for improved management. Nephrology (Carlton) 2006;11:542-8. [PMID: 17199795 DOI: 10.1111/j.1440-1797.2006.00701.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
141 Hiragi S, Tamura H, Goto R, Kuroda T. The effect of model selection on cost-effectiveness research: a comparison of kidney function-based microsimulation and disease grade-based microsimulation in chronic kidney disease modeling. BMC Med Inform Decis Mak 2018;18:94. [PMID: 30413200 DOI: 10.1186/s12911-018-0678-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
142 Bignelli AT, Barberato SH, Aveles P, Abensur H, Pecoits-filho R. The Impact of Living Donor Kidney Transplantation on Markers of Cardiovascular Risk in Chronic Kidney Disease Patients. Blood Purif 2007;25:233-41. [DOI: 10.1159/000101028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
143 Kaltsouda A, Skapinakis P, Damigos D, Ikonomou M, Kalaitzidis R, Mavreas V, Siamopoulos KC. Defensive coping and health-related quality of life in chronic kidney disease: a cross-sectional study. BMC Nephrol 2011;12:28. [PMID: 21689443 DOI: 10.1186/1471-2369-12-28] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
144 Powe NR. Health-Related Quality of Life in CKD-Advancing Patient-Centered Research to Transform Patient Care. Clin J Am Soc Nephrol 2016;11:1123-4. [PMID: 27246011 DOI: 10.2215/CJN.04730416] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
145 Offurum A, Wagner LA, Gooden T. Adverse safety events in patients with Chronic Kidney Disease (CKD). Expert Opin Drug Saf 2016;15:1597-607. [PMID: 27648959 DOI: 10.1080/14740338.2016.1236909] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
146 Lee YJ, Kim MS, Cho S, Kim SR. Association of depression and anxiety with reduced quality of life in patients with predialysis chronic kidney disease. Int J Clin Pract 2013;67:363-8. [PMID: 23521328 DOI: 10.1111/ijcp.12020] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 7.2] [Reference Citation Analysis]
147 Klinghoffer Z, Tarride JE, Novara G, Ficarra V, Kapoor A, Shayegan B, Braga LH. Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: Adjusting for the burden of ensuing chronic kidney disease. Can Urol Assoc J 2013;7:108-13. [PMID: 23671525 DOI: 10.5489/cuaj.502] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
148 McKercher C, Sanderson K, Jose MD. Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy. Nephrology (Carlton) 2013;18:585-91. [PMID: 23876102 DOI: 10.1111/nep.12138] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
149 Kefale B, Alebachew M, Tadesse Y, Engidawork E. Quality of life and its predictors among patients with chronic kidney disease: A hospital-based cross sectional study. PLoS One 2019;14:e0212184. [PMID: 30811447 DOI: 10.1371/journal.pone.0212184] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
150 Noiri E, Nagano N, Negishi K, Doi K, Miyata S, Abe M, Tanaka T, Okamoto K, Hanafusa N, Kondo Y, Ishizaka N, Fujita T. Efficacy of Darbepoetin in Doxorubicin-Induced Cardiorenal Injury in Rats. Nephron Exp Nephrol 2006;104:e6-e14. [DOI: 10.1159/000093258] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
151 Kelly OJ, Huang MC, Liao HY, Lin CC, Tung TY, Cheng RW, Wang MY, Yalawar M, Hwang SJ. A Low-Protein Diet with a Renal-Specific Oral Nutrition Supplement Helps Maintain Nutritional Status in Patients with Advanced Chronic Kidney Disease. J Pers Med 2021;11:1360. [PMID: 34945832 DOI: 10.3390/jpm11121360] [Reference Citation Analysis]
152 Adua E, Anto EO, Roberts P, Kantanka OS, Aboagye E, Wang W. The potential of N-glycosylation profiles as biomarkers for monitoring the progression of Type II diabetes mellitus towards diabetic kidney disease. J Diabetes Metab Disord 2018;17:233-46. [PMID: 30918859 DOI: 10.1007/s40200-018-0365-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
153 Riaño-galán I, Málaga S, Rajmil L, Ariceta G, Navarro M, Loris C, Vallo A. Quality of life of adolescents with end-stage renal disease and kidney transplant. Pediatr Nephrol 2009;24:1561-8. [DOI: 10.1007/s00467-009-1175-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
154 Ross EA, Hollen TL, Fitzgerald BM. Observational study of an Arts-in-Medicine Program in an outpatient hemodialysis unit. Am J Kidney Dis 2006;47:462-8. [PMID: 16490625 DOI: 10.1053/j.ajkd.2005.11.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
155 Soni RK, Porter AC, Lash JP, Unruh ML. Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions. Adv Chronic Kidney Dis 2010;17:e17-26. [PMID: 20610351 DOI: 10.1053/j.ackd.2010.04.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
156 Davis-Ajami ML, Wu J, Downton K, Ludeman E, Noxon V. Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility. Biologics 2014;8:155-67. [PMID: 24790409 DOI: 10.2147/BTT.S27578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
157 Kimel M, Leidy NK, Mannix S, Dixon J. Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease. Value Health 2008;11:57-75. [PMID: 18237361 DOI: 10.1111/j.1524-4733.2007.00215.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
158 Elliott S, Pham E, Macdougall IC. Erythropoietins: A common mechanism of action. Experimental Hematology 2008;36:1573-84. [DOI: 10.1016/j.exphem.2008.08.003] [Cited by in Crossref: 161] [Cited by in F6Publishing: 145] [Article Influence: 11.5] [Reference Citation Analysis]
159 Reboredo MDM, Henrique DMN, Bastos MG, Paula RBD. Exercício físico em pacientes dialisados. Rev Bras Med Esporte 2007;13:427-30. [DOI: 10.1590/s1517-86922007000600014] [Cited by in Crossref: 14] [Article Influence: 0.9] [Reference Citation Analysis]
160 Cunningham J, Floege J, London G, Rodriguez M, Shanahan CM. Clinical outcomes in secondary hyperparathyroidism and the potential role of calcimimetics. NDT Plus 2008;1:i29-35. [PMID: 25983954 DOI: 10.1093/ndtplus/sfm042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
161 Tan SMQ, Chiew Y, Ahmad B, Kadir KA. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial. Nutrients 2018;10:E1315. [PMID: 30227659 DOI: 10.3390/nu10091315] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
162 Feng L, Yap KB, Ng TP. Depressive Symptoms in Older Adults with Chronic Kidney Disease: Mortality, Quality of Life Outcomes, and Correlates. The American Journal of Geriatric Psychiatry 2013;21:570-9. [DOI: 10.1016/j.jagp.2012.12.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
163 Shutto Y, Yamabe H, Shimada M, Fujita T, Nakamura N. Quality of life in patients with minimal change nephrotic syndrome. ScientificWorldJournal 2013;2013:124315. [PMID: 23533341 DOI: 10.1155/2013/124315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
164 Bonner A, Caltabiano M, Berlund L. Quality of life, fatigue, and activity in Australians with chronic kidney disease: A longitudinal study: Quality of life, fatigue, and activity. Nurs Health Sci 2013;15:360-7. [DOI: 10.1111/nhs.12038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
165 Zhao B, Zhang L, Ji P, Lin J, Han J, Li J, Zhou Z, Wang H, Qiu L, Hong X, Williams W, Chen L. Bridging "Office-Based Care" With the "Virtual Practice Care Model": Evolving Care for Chronic Kidney Disease Patients in the COVID-19 Pandemic-And Beyond. Front Med (Lausanne) 2020;7:568201. [PMID: 33240903 DOI: 10.3389/fmed.2020.568201] [Reference Citation Analysis]
166 Okubo R, Kai H, Kondo M, Saito C, Yoh K, Morito N, Usui J, Yamagata K. Health-related quality of life and prognosis in patients with chronic kidney disease: a 3-year follow-up study. Clin Exp Nephrol 2014;18:697-703. [PMID: 24198050 DOI: 10.1007/s10157-013-0901-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
167 Besarab A, Salifu MO, Lunde NM, Bansal V, Fishbane S, Dougherty FC, Beyer U. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease. Clinical Therapeutics 2007;29:626-39. [DOI: 10.1016/j.clinthera.2007.04.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
168 Harrison LE, Burton JO, Szeto CC, Li PK, McIntyre CW. Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance? PLoS One 2012;7:e40209. [PMID: 22768256 DOI: 10.1371/journal.pone.0040209] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
169 Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] [Reference Citation Analysis]
170 Kumnig M, Jowsey-gregoire SG. Psychological and Psychosocial Aspects of Limb Transplantation. In: Sher Y, Maldonado JR, editors. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Cham: Springer International Publishing; 2019. pp. 365-76. [DOI: 10.1007/978-3-319-94914-7_35] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
171 Hull KL, March DS, Churchward DR, Graham‐brown MP, Burton JO. The effect of extended‐hours hemodialysis on outcomes: A systematic review and meta‐analysis. Hemodialysis International 2020;24:133-47. [DOI: 10.1111/hdi.12828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
172 Akchurin OM. Chronic Kidney Disease and Dietary Measures to Improve Outcomes. Pediatr Clin North Am 2019;66:247-67. [PMID: 30454747 DOI: 10.1016/j.pcl.2018.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
173 Brunetto MA, Ruberti B, Halfen DP, Caragelasco DS, Vendramini THA, Pedrinelli V, Macedo HT, Jeremias JT, Pontieri CFF, Ocampos FMM, Colnago LA, Kogika MM. Healthy and Chronic Kidney Disease (CKD) Dogs Have Differences in Serum Metabolomics and Renal Diet May Have Slowed Disease Progression. Metabolites 2021;11:782. [PMID: 34822440 DOI: 10.3390/metabo11110782] [Reference Citation Analysis]
174 Kumakura S, Sato E, Sekimoto A, Hashizume Y, Yamakage S, Miyazaki M, Ito S, Harigae H, Takahashi N. Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease. Toxins (Basel) 2021;13:50. [PMID: 33440677 DOI: 10.3390/toxins13010050] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
175 Picascia A, Grimaldi V, Paolillo R, Vasco M, Casamassimi A, De Luca FP, Cavalca F, Schiano C, Napoli C. Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation. Ren Fail 2014;36:585-8. [PMID: 24456257 DOI: 10.3109/0886022X.2014.880326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Legrand K, Speyer E, Stengel B, Frimat L, Ngueyon Sime W, Massy ZA, Fouque D, Laville M, Combe C, Jacquelinet C, Durand AC, Edet S, Gentile S, Briançon S, Ayav C. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France. American Journal of Kidney Diseases 2020;75:868-78. [DOI: 10.1053/j.ajkd.2019.08.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
177 Vanholder RC, Eloot S, Glorieux GL. Future Avenues to Decrease Uremic Toxin Concentration. Am J Kidney Dis 2016;67:664-76. [PMID: 26500179 DOI: 10.1053/j.ajkd.2015.08.029] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
178 Erez G, Selman L, Murtagh FE. Measuring health-related quality of life in patients with conservatively managed stage 5 chronic kidney disease: limitations of the Medical Outcomes Study Short Form 36: SF-36. Qual Life Res 2016;25:2799-809. [PMID: 27522214 DOI: 10.1007/s11136-016-1313-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
179 Canney M, Sexton E, Tobin K, Kenny RA, Little MA, O'Seaghdha CM. The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker. Clin Kidney J 2018;11:259-64. [PMID: 29644068 DOI: 10.1093/ckj/sfx084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
180 Peipert JD, Caicedo JC, Friedewald JJ, Abecassis MMI, Cella D, Ladner DP, Butt Z. Trends and predictors of multidimensional health-related quality of life after living donor kidney transplantation. Qual Life Res 2020;29:2355-74. [PMID: 32285345 DOI: 10.1007/s11136-020-02498-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
181 Mozaffari H, Ajabshir S, Alizadeh S. Dietary Approaches to Stop Hypertension and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies. Clin Nutr 2020;39:2035-44. [PMID: 31669002 DOI: 10.1016/j.clnu.2019.10.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
182 Schnelle J, Osterweil D, Globe D, Sciarra A, Audhya P, Barlev A. Chronic Kidney Disease, Anemia, and the Association Between Chronic Kidney Disease-Related Anemia and Activities of Daily Living in Older Nursing Home Residents. Journal of the American Medical Directors Association 2009;10:120-6. [DOI: 10.1016/j.jamda.2008.08.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
183 Cichota LC, Moresco RN, Duarte MM, da Silva JE. Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal 2008;22:1-5. [PMID: 18200583 DOI: 10.1002/jcla.20226] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
184 Ryu JH, Koo TY, Ro H, Cho JH, Kim MG, Huh KH, Park JB, Lee S, Han S, Kim J, Oh KH, Yang J; KNOW-KT Study group. Better health-related quality of life in kidney transplant patients compared to chronic kidney disease patients with similar renal function. PLoS One 2021;16:e0257981. [PMID: 34606505 DOI: 10.1371/journal.pone.0257981] [Reference Citation Analysis]
185 Rajkumar T, Mazid S, Vucak‐dzumhur M, Sykes TM, Elder GJ. Health‐related quality of life following kidney and simultaneous pancreas kidney transplantation. Nephrology 2019. [DOI: 10.1111/nep.13523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
186 Agarwal R. Developing a self-administered CKD symptom assessment instrument. Nephrol Dial Transplant 2010;25:160-6. [PMID: 19717826 DOI: 10.1093/ndt/gfp426] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
187 Zyga S, Alikari V, Sachlas A, Stathoulis J, Aroni A, Theofilou P, Panoutsopoulos G. Management of Pain and Quality of Life in Patients with Chronic Kidney Disease Undergoing Hemodialysis. Pain Manag Nurs 2015;16:712-20. [PMID: 26162558 DOI: 10.1016/j.pmn.2015.03.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
188 Seliger S, Fox KM, Gandra SR, Bradbury B, Hsu VD, Walker L, Chiou CF, Fink JC. Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study. Clin J Am Soc Nephrol. 2010;5:882-888. [PMID: 20299377 DOI: 10.2215/cjn.07171009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
189 Akyol AD, Yildirim Y, Toker E, Yavuz B. The use of complementary and alternative medicine among chronic renal failure patients. J Clin Nurs 2011;20:1035-43. [PMID: 21320219 DOI: 10.1111/j.1365-2702.2010.03498.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
190 Gemmell LA, Terhorst L, Jhamb M, Unruh M, Myaskovsky L, Kester L, Steel JL. Gender and Racial Differences in Stress, Coping, and Health-Related Quality of Life in Chronic Kidney Disease. J Pain Symptom Manage 2016;52:806-12. [PMID: 27697565 DOI: 10.1016/j.jpainsymman.2016.05.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
191 Moe SM, Saifullah A, LaClair RE, Usman SA, Yu Z. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. Clin J Am Soc Nephrol 2010;5:299-306. [PMID: 20056760 DOI: 10.2215/CJN.07131009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
192 van Dellen D, Burnapp L, Citterio F, Mamode N, Moorlock G, van Assche K, Zuidema WC, Lennerling A, Dor FJ. Pre-emptive live donor kidney transplantation-moving barriers to opportunities: An ethical, legal and psychological aspects of organ transplantation view. World J Transplant 2021; 11(4): 88-98 [PMID: 33954087 DOI: 10.5500/wjt.v11.i4.88] [Reference Citation Analysis]
193 Lazarus ER. Effectiveness of education and exercise on quality of life among patients undergoing hemodialysis. Clinical Epidemiology and Global Health 2019;7:402-8. [DOI: 10.1016/j.cegh.2018.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
194 Cabrera VJ, Hansson J, Kliger AS, Finkelstein FO. Symptom Management of the Patient with CKD: The Role of Dialysis. Clin J Am Soc Nephrol 2017;12:687-93. [PMID: 28148557 DOI: 10.2215/CJN.01650216] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
195 Macdonald JH, Fearn L, Jibani M, Marcora SM. Exertional fatigue in patients with CKD. Am J Kidney Dis 2012;60:930-9. [PMID: 22883133 DOI: 10.1053/j.ajkd.2012.06.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
196 Parikh A, Shaw A. The Economics of Renal Failure and Kidney Disease in Critically Ill Patients. Critical Care Clinics 2012;28:99-111. [DOI: 10.1016/j.ccc.2011.10.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
197 Bernieh B, Abouchacra S, Boobes Y, Al Hakim MR, Nagelkerke N, Chaaban A, Ahmed M, Hussain Q, Jack HE, Abayechi F, Khan I, Gebran N. Comparison between short- and long-acting erythropoiesis-stimulating agents in hemodialysis patients: target hemoglobin, variability, and outcome. Int Urol Nephrol 2014;46:453-9. [PMID: 24448756 DOI: 10.1007/s11255-013-0640-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
198 Wilson P, Wood C. Biosimilar ESAs: a comparative review. J Ren Care 2015;41:53-61. [PMID: 25348203 DOI: 10.1111/jorc.12099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
199 Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol. 2006;38:295-310. [PMID: 16868702 DOI: 10.1007/s11255-006-0064-8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 4.3] [Reference Citation Analysis]
200 Lemos CF, Rodrigues MP, Veiga JR. Family income is associated with quality of life in patients with chronic kidney disease in the pre-dialysis phase: a cross sectional study. Health Qual Life Outcomes 2015;13:202. [PMID: 26690667 DOI: 10.1186/s12955-015-0390-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
201 Canaud B, Mingardi G, Braun J, Aljama P, Kerr PG, Locatelli F, Villa G, Van Vlem B, McMahon AW, Kerloëguen C, Beyer U; STRIATA Study Investigators. Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study. Nephrol Dial Transplant 2008;23:3654-61. [PMID: 18586762 DOI: 10.1093/ndt/gfn320] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
202 Farragher JF, Zhang J, Harrison TG, Ravani P, Elliott MJ, Hemmelgarn B. The Association Between Estimated Glomerular Filtration Rate and Hospitalization for Fatigue: A Population-Based Cohort Study. Can J Kidney Health Dis 2021;8:20543581211001224. [PMID: 33796323 DOI: 10.1177/20543581211001224] [Reference Citation Analysis]
203 Ramer S, Germain A, Dohar S, Unruh M. Event-related distress in kidney disease patients. Nephrol Dial Transplant 2012;27:299-303. [PMID: 21624943 DOI: 10.1093/ndt/gfr305] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
204 Senanayake S, Gunawardena N, Palihawadana P, Senanayake S, Karunarathna R, Kumara P, Kularatna S. Health related quality of life in chronic kidney disease; a descriptive study in a rural Sri Lankan community affected by chronic kidney disease. Health Qual Life Outcomes 2020;18:106. [PMID: 32326945 DOI: 10.1186/s12955-020-01369-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
205 Fisher EB, Thorpe CT, Mcevoy Devellis B, Devellis RF. Healthy Coping, Negative Emotions, and Diabetes Management. Diabetes Educ 2007;33:1080-103. [DOI: 10.1177/0145721707309808] [Cited by in Crossref: 135] [Cited by in F6Publishing: 114] [Article Influence: 22.5] [Reference Citation Analysis]
206 Ibrahim N, Teo SS, Che Din N, Abdul Gafor AH, Ismail R. The Role of Personality and Social Support in Health-Related Quality of Life in Chronic Kidney Disease Patients. PLoS One 2015;10:e0129015. [PMID: 26131714 DOI: 10.1371/journal.pone.0129015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
207 Schaepe C, Bergjan M. Educational interventions in peritoneal dialysis: a narrative review of the literature. Int J Nurs Stud 2015;52:882-98. [PMID: 25616708 DOI: 10.1016/j.ijnurstu.2014.12.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
208 Katsi V, Kallistratos MS, Kontoangelos K, Sakkas P, Souliotis K, Tsioufis C, Nihoyannopoulos P, Papadimitriou GN, Tousoulis D. Arterial Hypertension and Health-Related Quality of Life. Front Psychiatry 2017;8:270. [PMID: 29255431 DOI: 10.3389/fpsyt.2017.00270] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
209 Kim YJ, Choi WJ, Ham S, Kang SK, Lee W. Association between occupational or environmental noise exposure and renal function among middle-aged and older Korean adults: a cross-sectional study. Sci Rep 2021;11:24127. [PMID: 34916574 DOI: 10.1038/s41598-021-03647-4] [Reference Citation Analysis]
210 Mohammadi S, Asghari G, Emami-Naini A, Mansourian M, Badri S. Herbal Supplement Use and Herb-drug Interactions among Patients with Kidney Disease. J Res Pharm Pract 2020;9:61-7. [PMID: 33102379 DOI: 10.4103/jrpp.JRPP_20_30] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 Tong A, Henning P, Wong G, Mctaggart S, Mackie F, Carroll RP, Craig JC. Experiences and Perspectives of Adolescents and Young Adults With Advanced CKD. American Journal of Kidney Diseases 2013;61:375-84. [DOI: 10.1053/j.ajkd.2012.09.024] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
212 Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Watanabe Y, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; JET Study Group. Low hemoglobin levels and hypo-responsiveness to erythropoiesis-stimulating agent associated with poor survival in incident Japanese hemodialysis patients. Ther Apher Dial 2014;18:404-13. [PMID: 24571446 DOI: 10.1111/1744-9987.12155] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
213 Nagasawa H, Tachi T, Sugita I, Esaki H, Yoshida A, Kanematsu Y, Noguchi Y, Kobayashi Y, Ichikawa E, Tsuchiya T, Teramachi H. The Effect of Quality of Life on Medication Compliance Among Dialysis Patients. Front Pharmacol 2018;9:488. [PMID: 29950988 DOI: 10.3389/fphar.2018.00488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]